Trademark Overview
On Monday, January 13, 2025, a trademark application was filed for KIND ONE-DAY TMS PROTOCOL with the United States Patent and Trademark Office. The USPTO has given the KIND ONE-DAY TMS PROTOCOL trademark a serial number of 98957032. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, September 24, 2025. This trademark is owned by Georgine Nanos. The KIND ONE-DAY TMS PROTOCOL trademark is filed in the Advertising, Business and Retail Services, Personal, Legal & Social Services, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Educational services, namely, conducting training programs for clinicians in the use of transcranial magnetic stimulation technology and protocols; providing training of clinicians for certification in the field of transcranial magnetic stimulation technology and protocols; educational services, namely, conducting workshops in the field of mental health and cognitive wellness and distribution of educational materials in connection therewith
Marketing services; branding services, namely, brand development services and business consulting services for licensed providers offering transcranial magnetic stimulation protocols
Licensing of intellectual property in the field of treatment protocols for healthcare providers
Mental health services; medical services, namely, transcranial magnetic stimulation; medical treatment of neuro-psychiatric diseases; medical treatment of major depressive disorder and anxious depression with transcranial magnetic stimulation therapy; medical services, namely, the use of transcranial magnetic stimulation to treat major depressive disorder, anxious depression, and obsessive-compulsive disorder; cognitive wellness services, namely, mental health services and behavioral health services; medical services, namely, implementing medical protocols for mental health and neurological treatments, including accelerated transcranial magnetic stimulation (TMS) protocols; medical services, namely, implementing accelerated mental health treatment protocols; psychiatric services, namely, providing psychiatric therapies for treatment-resistant depression, providing transcranial magnetic stimulation therapies, administering ketamine therapies, administering nasal spray medication taken w...
Clinical research and scientific studies in the field of the efficacy and benefits of accelerated mental health treatment protocols; collaboration with academic and medical institutions for the further development of accelerated transcranial magnetic stimulation protocols